Approaches for Applications of Physiologically Based Pharmacokinetic Models in Risk Assessment

REFERENCES

• Agutter , P. S. and Wheatley , D. N. 2004 . Metabolic scaling: Consensus or controversy? . Theor. Biol. Med. Model. , 1 : 13
   PubMedGoogle Scholar
• Andersen , M. E. , Mills , J. J. , Gargas , M. L. , Kedderis , L. , Birnbaum , L. S. , Neubert , D. and Greenlee , W. F. 1993 . Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment . Risk Anal. , 13 : 25 – 36 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. 1995 . Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment . Toxicol. Lett. , 79 : 35 – 44 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. , Clewell , H. J. III , Gargas , M. L. , Smith , F. A. and Reitz , R. H. 1987 . Physiologically based pharmacokinetics and the risk assessment process for methylene chloride . Toxicol. Appl. Pharmacol. , 87 : 185 – 205 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. and Dennison , J. E. 2001 . Mode of action and tissue dosimetry in current and future risk assessments . Sci. Total Environ. , 274 : 3 – 14 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. , Clewell , H. J. , Gearhart , J. , Allen , B. C. and Barton , H. A. 1997 . Pharmacodynamic model of the rat estrus cycle in relation to endocrine disruption . J. Toxicol. Environ. Health , 52 : 189 – 209 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. , Sarangapani , R. , Gentry , R. , Clewell , H. , Covington , T. and Frederick , C. B. 1999 . Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: an example with acrylic acid . Toxicol. Sci. , 57 : 312 – 325 .
   Web of Science ®Google Scholar
• Andersen , M. E. , Green , T. , Frederick , C. B. and Bogdanffy , M. S. 2002 . Physiologically based pharmacokinetic (PBPK) models for nasal tissue dosimetry of organic esters: Assessing the state-of-knowledge and risk assessment applications with methyl methacrylate and vinyl acetate . Regul. Toxicol. Pharmacol. , 36 : 234 – 245 .
   PubMed Web of Science ®Google Scholar
• Andersen , M. E. and Jarabek , A. M. 2001 . Nasal tissue dosimetry-issues and approaches for "Category 1" gases: A report on a meeting held in Research Triangle Park, NC, February 11–12, 1998 . Inhal. Toxicol. , 13 : 415 – 435 .
   PubMed Web of Science ®Google Scholar
• Armitage , P. and Doll , R. 1957 . A two-stage theory of carcinogenesis in relation to the age distribution of human cancer . Br. J. Cancer , 11 : 161 – 169 .
   PubMed Web of Science ®Google Scholar
• Asgharian , B. , Wood , R. and Schlesinger , R. B. 1995 . Empirical modeling of particle deposition in the alveolar region of the lungs: A basis for interspecies extrapolation . Fundam. Appl. Toxicol. , 27 : 232 – 238 .
   PubMedGoogle Scholar
• Aylward , L. L. , Hays , S. M. , Karch , N. J. and Paustenbach , D. J. 1996 . Relative susceptibility of animals and humans to the cancer hazard posed by 2,3,7,8-tetrachlorodibenzo-p-dioxin using internal measures of dose . Environ. Sci. Technol. , 30 : 3534 – 3543 .
   Web of Science ®Google Scholar
• Barton , H. A. , Deisinger , P. J. , English , J. C. , Gearhart , J. N. , Faber , W. D. , Tyler , T. R. , Banton , M. I. , Teeguarden , J. and Andersen , M. E. 2000 . Family approach for estimating reference concentrations/doses for series of related organic chemicals . Toxicol. Sci. , 54 : 251 – 261 .
   PubMed Web of Science ®Google Scholar
• Barton , H. A. , Chiu , W. A. , Setzer , R. W. , Andersen , M. E. , Bailer , A. J. , Bois , F. Y. , Dewoskin , R. S. , Hays , S. , Johanson , G. , Jones , N. , Loizou , G. , Macphail , R. C. , Portier , C. J. , Spendiff , M. and Tan , Y. M. 2007 . Characterizing uncertainty and variability in physiologically-based pharmacokinetic (PBPK) models: State of the science and needs for research and implementation . Toxicol. Sci. , 99 : 395 – 402 .
   PubMed Web of Science ®Google Scholar
• Benet , L. Z. , Kroetz , D. L. and Sheiner , L. B. 1996 . “ Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism, and elimination ” . In Goodman and Gilman's The pharmacological basis of therapeutics , Edited by: Hardman , J. G. and Limbird , L. E. 3 – 27 . New York : McGraw-Hill .
   Google Scholar
• Benignus , V. A. , Boyes , W. K. and Bushnell , P. J. 1998 . A dosimetric analysis of behavioral effects of acute toluene exposure in rats and humans . Toxicol. Sci. , 43 : 186 – 195 .
   PubMed Web of Science ®Google Scholar
• Bogdanffy , M. S. , Sarangapani , R. , Plowchalk , D. R. , Jarabek , A. and Andersen , M. E. 1999 . A biologically risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity . Toxicol. Sci. , 51 : 19 – 35 .
   PubMed Web of Science ®Google Scholar
• Bogdanffy , M. S. , Plowchalk , D. R. , Sarangapani , R. , Starr , T. B. and Andersen , M. E. 2001 . Mode-of-action-based dosimeters for interspecies extrapolation on vinyl acetate inhalation risk . Inhal. Toxicol. , 13 : 377 – 396 .
   PubMed Web of Science ®Google Scholar
• Bogdanffy , M. S. and Sarangapani , R. 2003 . Physiologically-based kinetic modeling of vapours toxic to the respiratory tract . Toxicol. Lett. , 138 : 103 – 117 .
   PubMed Web of Science ®Google Scholar
• Bouchard , M. , Brunet , R. C. , Droz , P. O. and Carrier , G. 2001 . A biologically based dynamic model for predicting the disposition of methanol and its metabolites in animals and humans . Toxicol. Sci. , 64 : 169 – 184 .
   PubMed Web of Science ®Google Scholar
• Boyes , W. K. , Bushnell , P. J. , Crofton , K. M. , Evans , M. and Simmons , J. E. 2000 . Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario . Environ. Health Perspect. , 108 ( Suppl. 2 ) : 317 – 322 .
   PubMed Web of Science ®Google Scholar
• Brown , R. P. , Delp , M. D. , Lindstedt , S. L. , Rhomberg , L. R. and Beliles , R. P. 1997 . Physiological parameter values for physiologically based pharmacokinetic models . Toxicol. Ind. Health , 13 : 407 – 484 .
   PubMed Web of Science ®Google Scholar
• Bruckner , J. V. , Keys , D. A. and Fisher , J. W. 2004 . The Acute Exposure Guideline Level (AEGL) program: Applications of physiologically based pharmacokinetic modeling . J. Toxicol. Environ. Health A , 67 : 621 – 634 .
   PubMed Web of Science ®Google Scholar
• Bush , M. L. , Frederick , C. B. , Kimbell , J. S. and Ultman , J. S. 1998 . A CFD–PBPK hybrid model for simulating gas and vapor uptake in the rat nose . Toxicol. Appl. Pharmacol. , 150 : 133 – 145 .
   PubMed Web of Science ®Google Scholar
• Bushnell , P. J. 1997 . Concentration–time relationships for the effects of inhaled trichloroethylene on signal detection behavior in rats . Fundam. Appl. Toxicol. , 36 : 30 – 38 .
   PubMedGoogle Scholar
• Canuel , G. , Viau , C. and Krishnan , K. A modeling framework for back-calculating ambient concentrations from data on biomarkers. International Conference on Health Sciences Simulation . Proc. International Conference on Health Sciences Simulation . San Diego, CA. pp. 97 – 102 .
   Google Scholar
• Casanova , M. , Conolly , R. B. and Heck , and H. A. 1996 . DNA–protein cross-links (DPX) and cell proliferation in B6C3F1 mice but not Syrian golden hamsters exposed to dichloromethane: Pharmacokinetics and risk assessment with DPX as dosimeter . Fundam. Appl. Toxicol. , 31 : 103 – 116 .
   PubMedGoogle Scholar
• Chen , C. W. 1993 . Armitage–Doll two-stage model: Implications and extension . Risk Anal. , 13 : 273 – 279 .
   PubMed Web of Science ®Google Scholar
• Chiu , W. A. , Barton , H. A. , DeWoskin , R. S. , Schlosser , P. , Thompson , C. M. , Sonawane , B. , Lipscomb , J. C. and Krishnan , K. 2007 . Evaluation of physiologically based pharmacokinetic models for use in risk assessment . J. Appl. Toxicol. , 27 : 218 – 237 .
   PubMed Web of Science ®Google Scholar
• Clark , L. H. , Setzer , R. W. and Barton , H. A. 2004 . Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment . Risk Anal. , 24 : 1697 – 1717 .
   PubMed Web of Science ®Google Scholar
• Clarke , D. O. , Duignan , J. M. and Welsch , F. 1992 . 2-Methoxyacetic acid dosimetry-teratogenicity relationships in CD-1 mice exposed to 2-methoxyethanol . Toxicol. Appl. Pharmacol. , 114 : 77
   PubMed Web of Science ®Google Scholar
• Clarke , D. O. , Elswick , B. A. , Welsch , F. and Conolly , R. B. 1993 . Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: A physiologically-based mathematical model . Toxicol. Appl. Pharmacol. , 121 : 239 – 252 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. III and Andersen , M. E. 1985 . Risk assessment extrapolations and physiological modeling . Toxicol. Ind. Health , 1 : 111 – 131 .
   PubMedGoogle Scholar
• Clewell , H. J. III and Andersen , M. E. 1987 . Dose, species and route extrapolation using physiologically-based pharmacokinetic models . Drink. Water Health , 8 : 159 – 182 .
   Google Scholar
• Clewell , H. J. III and Andersen , M. E. 2004 . Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: An example with trichloroethylene . Crit. Rev. Toxicol. , 34 : 385 – 445 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. III and Jarnot , B. M. 1994 . Incorporation of pharmacokinetics in noncancer risk assessment: Example with chloropentafluorobenzene . Risk Anal. , 14 : 265 – 276 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. III , Andersen , M. E. , Willis , R. J. and Latriano , L. 1997 . A physiologically based pharmacokinetic model for retinoic acid and its metabolites . J. Acad Dermatol. , 36 : S77 – S85 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. III , Gentry , P. R. , Covington , T. R. and Gearhart , J. M. 2000 . Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment . Environ. Health Perspect. , 108 : 283 – 305 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. , Gentry , P. R. , Gearhart , J. M. , Allen , B. C. and Andersen , M. E. 2001 . Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model . Sci. Total Environ. , 274 : 37 – 66 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. III , Andersen , M. E. and Barton , H. A. 2002a . A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment . Environ. Health Perspect. , 110 : 85 – 93 .
   PubMed Web of Science ®Google Scholar
• Clewell , H.J. , Teeguarden , J. , McDonald , T. , Sarangapani , R. , Lawrence , G. , Covington , T. , Gentry , R. and Shipp , A. 2002b . Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry . Crit. Rev. Toxicol. , 32 : 329 – 389 .
   PubMed Web of Science ®Google Scholar
• Clewell , H. J. , Gentry , P. R. , Covington , T. R. , Sarangapani , R. and Teeguarden , J. G. 2004 . Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry . Toxicol. Sci. , 79 : 381 – 393 .
   PubMed Web of Science ®Google Scholar
• Cohen , S. M. and Ellwein , L. B. 1990 . Cell proliferation in carcinogenesis . Science , 249 : 1007 – 1011 .
   PubMed Web of Science ®Google Scholar
• Collins , J. 1987 . Prospective predictions and validations in anti-cancer therapy , 431 – 440 . Washington, DC : National Academy Press .
   Google Scholar
• Conolly , R. B. and Andersen , M. E. 1997 . Hepatic foci in rats after diethyl-nitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: Evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter . Toxicol. Appl. Pharmacol. , 146 : 281 – 293 .
   PubMed Web of Science ®Google Scholar
• Conolly , R. B. and Butterworth , B. E. 1995 . Biologically based dose response model for hepatic toxicity: A mechanistically based replacement for traditional estimates of noncancer risk . Toxicol. Lett. , 82–83 : 901 – 906 .
   PubMed Web of Science ®Google Scholar
• Conolly , R. B. and Kimbell , J. S. 1994 . Computer simulation of cell growth governed by stochastic processes: Application to clonal growth cancer models . Toxicol. Appl. Pharmacol. , 124 : 284 – 295 .
   PubMed Web of Science ®Google Scholar
• Conolly , R. B. , Kimbell , J. S. , Janszen , D. , Schlosser , P. M. , Kalisak , D. , Preston , J. and Miller , F. J. 2003 . Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat . Toxicol. Sci. , 75 : 432 – 447 .
   PubMed Web of Science ®Google Scholar
• Corley , R. A. , Bormett , G. A. and Ghanayem , B. I. 1994 . Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans . Toxicol. Appl. Pharmacol. , 129 : 61 – 79 .
   PubMed Web of Science ®Google Scholar
• Corley , R. A. , Markham , D. A. , Banks , C. , Delorme , P. , Masterman , A. and Houle , J. M. 1997 . Physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapor by humans . Fundam. Appl. Toxicol. , 39 : 120 – 130 .
   PubMedGoogle Scholar
• Corley , R. A. , Gordon , S. M. and Wallace , L. A. 2000 . Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures . Toxicol. Sci. , 53 : 13 – 23 .
   PubMed Web of Science ®Google Scholar
• Corley , R. A. , Mast , T. J. , Carney , E. W. , Rogers , J. M. and Daston , G. P. 2003 . Evaluation of physiologically based models of pregnancy and lactation for their application in children's health risk assessments . Crit. Rev. Toxicol. , 33 : 137 – 211 .
   PubMed Web of Science ®Google Scholar
• Cruzan , G. , Carlson , G. P. , Johnson , K. A. , Andrews , L. S. , Banton , M. I. , Bevan , C. and Cushman , J. R. 2002 . Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites . Regul. Toxicol. Pharmacol. , 35 : 308 – 319 .
   PubMed Web of Science ®Google Scholar
• Csanady , G. A. , Kreuzer , P. E. , Baur , C. and Filser , J. G. 1996 . A physiological toxicokinetic model for 1,3-butadiene in rodents and man: Blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts—Relevance of glutathione depletion . Toxicology , 113 : 300 – 305 .
   PubMed Web of Science ®Google Scholar
• DeWoskin , R. S. , Lipscomb , J. C. , Thompson , C. M. , Chiu , W. A. , Schlosser , P. , Smallwood , C. , Swartout , J. , Teuschler , K. and Marcus , A. 2007 . “ Pharmacokinetic/physiologically based pharmacokinetic models in integrated risk information system assessments ” . In Toxicokinetics and risk assessment , Edited by: Lipscomb , J. C. and Ohnaian , E. V. 301 – 348 . New York : Informa Healthcare .
   Google Scholar
• Dorne , J. L. , Walton , K. and Renwick , A. G. 2001a . Human variability in glucuronidation in relation to uncertainty factors for risk assessment . Food Chem. Toxicol. , 39 : 1153 – 1173 .
   PubMed Web of Science ®Google Scholar
• Dorne , J. L. , Walton , K. and Renwick , A. G. 2001b . Uncertainty factors for chemical risk assessment. human variability in the pharmacokinetics of CYP1A2 probe substrates . Food Chem. Toxicol. , 39 : 681 – 696 .
   PubMed Web of Science ®Google Scholar
• Dorne , J. L. , Walton , K. , Slob , W. and Renwick , A. G. 2002 . Human variability in polymorphic CYP2D6 metabolism: Is the kinetic default uncertainty factor adequate? . Food Chem. Toxicol. , 40 : 1633 – 1656 .
   PubMed Web of Science ®Google Scholar
• Droz , P. O. , Berode , M. and Jang , J. Y. 1999 . Biological monitoring of tetrahydrofuran: Contribution of a physiologically based pharmacokinetic model . Am. Ind. Hyg. Assoc. J. , 60 : 243 – 248 .
   PubMed Web of Science ®Google Scholar
• el-Masri , H. A. , Bell , D. A. and Portier , C. J. 1999 . Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans . Toxicol. Appl. Pharmacol. , 158 : 221 – 230 .
   PubMed Web of Science ®Google Scholar
• Faustman , E. M. , Lewandowski , T. A. , Ponce , R. A. and Bartell , S. M. 1999 . Biologically based dose-response models for developmental toxicants: Lessons from methylmercury . Inhal. Toxicol. , 11 : 559 – 572 .
   PubMed Web of Science ®Google Scholar
• Fennell , T. R. , Sumner , S. C. and Walker , V. E. 1992 . A model for the formation and removal of hemoglobin adducts . Cancer Epidemiol. Biomarkers Prev. , 1 : 213 – 219 .
   PubMed Web of Science ®Google Scholar
• Fisher , J. W. and Allen , B. C. 1993 . Evaluating the risk of liver cancer in human exposed to trichloroethylene using physiological models . Risk Anal. , 13 : 87 – 95 .
   PubMed Web of Science ®Google Scholar
• Frederick , C. B. , Potter , D. W. , Chang-Mateu , M. I. and Andersen , M. E. 1992 . A physiologically-based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment . Toxicol. Appl. Pharmacol. , 114 : 246 – 260 .
   PubMed Web of Science ®Google Scholar
• Gearhart , J. M. , Jepson , G. W. , Clewell , H. J. III , Andersen , M. E. and Conolly , R. B. 1990 . Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate . Toxicol. Appl. Pharmacol. , 106 : 295 – 310 .
   PubMed Web of Science ®Google Scholar
• Gearhart , J. M. , Jepson , G. W. , Clewell , H. J. , Andersen , M. E. and Conolly , R. B. 1994 . Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters . Environ. Health Perspect. , 102 ( Suppl. 11 ) : 51 – 60 .
   PubMed Web of Science ®Google Scholar
• Gearhart , J. M. , Clewell , H. J. and Crump , K. S. 1995 . Pharmacokinetic dose estimates of mercury in children and dose-response curves of performance tests in a large epidemiological study . Water Air Soil Pollut. , 80 : 49 – 58 .
   Web of Science ®Google Scholar
• Gentry , P. R. , Covington , T. R. , Andersen , M. E. and Clewell , H. J. 2002 . Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration . Regul. Toxicol. Pharmacol. , 36 : 51 – 68 .
   PubMed Web of Science ®Google Scholar
• Gentry , P. R. , Covington , T. R. and Clewell , H. J. III. 2003 . Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation . Regul. Toxicol. Pharmacol. , 38 : 1 – 16 .
   PubMed Web of Science ®Google Scholar
• Gentry , P. R. , Haber , L. T. , McDonald , T. B. , Zhao , Q. , Covington , T. , Nance , P. , Clewell , H. J. III , Lipscomb , J. C. and Barton , H. A. 2004 . Data for physiologically based pharmacokinetic modeling in neonatal animals: Physiological parameters in mice and Sprague-Dawley rats . J. Child. Health , 2 : 363 – 411 .
   Google Scholar
• Gerrity , P. G. , Henry , C. J. and Birnbaum , L. 1990 . Principles of route–route extrapolation for risk assessment , New York : Elsevier .
   Google Scholar
• Ginsberg , G. , Hattis , D. , Russ , A. and Sonawane , B. 2004 . Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: Implications for assessing children's risks from environmental agents . J. Toxicol. Environ. Health A , 67 : 297 – 329 .
   PubMed Web of Science ®Google Scholar
• Haddad , S. , Beliveau , M. , Tardif , R. and Krishnan , K. 2001a . A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures . Toxicol. Sci. , 63 : 125 – 131 .
   PubMed Web of Science ®Google Scholar
• Haddad , S. , Restieri , C. and Krishnan , K. 2001b . Characterization of age-related changes in body weight and organ weights from birth to adolescence in humans . J. Toxicol. Environ. Health A , 64 : 453 – 464 .
   PubMed Web of Science ®Google Scholar
• Hanna , L. M. , Lou , S. R. , Su , S. and Jarabek , A. M. 2001 . Mass transport analysis: Inhalation RfC methods framework for interspecies dosimetric adjustment . Inhal. Toxicol. , 13 : 437 – 463 .
   PubMed Web of Science ®Google Scholar
• Himmelstein , K. J. and Lutz , R. J. 1979 . A review of the application of physiologically based pharmacokinetic modeling . J. Pharm. Biopharm. , 7 : 127 – 145 .
   PubMedGoogle Scholar
• Hurst , C. H. , DeVito , M. J. , Setzer , R. W. and Birnbaum , L. S. 2000 . Acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in pregnant Long Evans rats: Association of measured tissue concentrations with developmental effects . Toxicol. Sci. , 53 : 411 – 420 .
   PubMed Web of Science ®Google Scholar
• IPCS . 2005 . Chemical-specific adjustment factors (CSAFs) for interspecies differences and human variability in dose/concentration-response assessment: Guidance document for the use of data in dose/concentration-response assessment , Geneva : World Health Organization .
   Google Scholar
• Jarabek , A. M. 1995a . Interspecies extrapolation based on mechanistic determinants of chemical disposition . Hum. Ecol. Risk Assess. , 1 : 641 – 662 .
   Google Scholar
• Jarabek , A. M. 1995b . The application of dosimetry models to identify key processes and parameters for default dose-response assessment approaches . Toxicol. Lett. , 79 : 171 – 184 .
   PubMed Web of Science ®Google Scholar
• Jarabek , A. M. , Fisher , J. W. , Rubenstein , R. , Lipscomb , J. C. , Williams , R. J. , Vinegar , A. and McDougal , J. N. 1994 . Mechanistic insights aid the search for CFC substitutes: Risk assessment of HCFC-123 as an example . Risk Anal. , 14 : 231 – 250 .
   PubMed Web of Science ®Google Scholar
• Jonsson , F. and Johanson , G. 2001 . A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane . Toxicol. Appl. Pharmacol. , 174 : 99 – 112 .
   PubMed Web of Science ®Google Scholar
• Kenyon , E. M. , Kraichely , R. E. , Hudson , K. T. and Medinsky , M. A. 1996 . Differences in rates of benzene metabolism correlate with observed genotoxicity . Toxicol. Appl. Pharmacol. , 136 : 49 – 56 .
   PubMed Web of Science ®Google Scholar
• Kim , A. H. , Kohn , M. C. , Portier , C. J. and Walker , N. J. 2002 . Impact of physiologically based pharmacokinetic modeling on benchmark dose calculations for TCDD-induced biochemical responses . Regul. Toxicol. Pharmacol. , 36 : 287 – 296 .
   PubMed Web of Science ®Google Scholar
• Kimbell , J. S. , Gross , E. A. , Joyner , D. R. , Godo , M. N. and Morgan , K. T. 1993 . Application of computational fluid dynamics to regional dosimetry of inhaled chemicals in the upper respiratory tract of the rat . Toxicol. Appl. Pharmacol. , 121 : 253 – 263 .
   PubMed Web of Science ®Google Scholar
• Kirman , C. R. , Hays , S. M. , Kedderis , G. L. , Gargas , M. L. and Strother , D. E. 2000 . Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: An analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the rat . Risk Anal. , 20 : 135 – 151 .
   PubMed Web of Science ®Google Scholar
• Kohn , M. C. and Melnick , R. L. 1999 . A physiological model for ligand-induced accumulation of alpha 2u globulin in male rat kidney: Roles of protein synthesis and lysosomal degradation in the renal dosimetry of 2,4,4-trimethyl-2-pentanol . Toxicology , 136 : 89 – 105 .
   PubMed Web of Science ®Google Scholar
• Krishnan , K. and Andersen , M. E. 2007 . “ Physiologically based pharmacokinetic modeling in toxicology ” . In Principles and methods of toxicology , Edited by: Hayes , A. W. 231 – 292 . Philadelphia : Taylor & Francis .
   Google Scholar
• Krishnan , K. and Andersen , M.E. 2001 . “ Physiologically based pharmacokinetic modeling in toxicology ” . In Principles and methods of toxicology , Edited by: Hayes , A. W. 193 – 241 . Philadelphia : Taylor & Francis .
   Google Scholar
• Krishnan , K. , Gargas , M. L. , Fennell , T. R. and Andersen , M. E. 1992 . A physiologically based description of ethylene oxide dosimetry in the rat . Toxicol. Ind. Health , 8 : 121 – 140 .
   PubMed Web of Science ®Google Scholar
• Kumagai , S. and Matsunaga , I. 1995 . Physiologically based pharmacokinetic model for acetone . Occup. Environ. Med. , 52 : 344 – 352 .
   PubMed Web of Science ®Google Scholar
• Leroux , B.G. , Leisenring , W.M. , Moolgavkar , S.H. and Faustman , E.M. 1996 . A biologically-based dose-response model for development toxicology . Risk Anal. , 16 : 449 – 458 .
   PubMed Web of Science ®Google Scholar
• Leung , H. W. 1991 . Development and utilization of physiologically based pharmacokinetic models for toxicological applications . J. Toxicol. Environ. Health , 32 : 247 – 267 .
   PubMed Web of Science ®Google Scholar
• Leung , H. W. 1992 . Use of physiologically based pharmacokinetic models to establish biological exposure indexes . Am. Ind. Hyg. Assoc. J. , 53 : 369 – 374 .
   PubMed Web of Science ®Google Scholar
• Leung , H. W. and Paustenbach , D. J. 1990 . Cancer risk assessment for dioxane based upon a physiologically-based pharmacokinetic modeling approach . Toxicol. Lett. , 51 : 147 – 162 .
   PubMed Web of Science ®Google Scholar
• Levesque , B. , Ayotte , P. , Tardif , R. , Ferron , L. , Gingras , S. , Schlouch , E. , Gingras , G. , Levallois , P. and Dewailly , E. 2002 . Cancer risk associated with household exposure to chloroform . J. Toxicol. Environ. Health A , 65 : 489 – 502 .
   PubMed Web of Science ®Google Scholar
• Liao , K. H. , Dobrev , I. D. , Dennison , J. E. Jr. , Andersen , M. E. , Reisfeld , B. , Reardon , K. F. , Campain , J. A. , Wei , W. , Klein , M. T. , Quann , R. J. and Yang , R. S. 2002 . Application of biologically based computer modeling to simple or complex mixtures . Environ. Health Perspect. , 110 ( Suppl. 6 ) : 957 – 963 .
   PubMed Web of Science ®Google Scholar
• Lipscomb , J. C. 2004 . Evaluating the relationship between variance in enzyme expression and toxicant concentration in health risk assessment . Hum. Ecol. Risk Assess. , 10 : 39 – 55 .
   Web of Science ®Google Scholar
• Lipscomb , J. C. , Fisher , J. W. , Confer , P. D. and Byczkowski , J. Z. 1998 . In vitro to in vivo extrapolation for trichloroethylene metabolism in humans . Toxicol. Appl. Pharmacol. , 152 : 376 – 387 .
   PubMed Web of Science ®Google Scholar
• Lipscomb , J. C. , Teuschler , L. K. , Swartout , J. , Popken , D. , Cox , T. and Kedderis , G. L. 2003 . The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans . Risk Anal. , 23 : 1221 – 1238 .
   PubMed Web of Science ®Google Scholar
• Loizou , G. , Spendiff , M. , Barton , H. A. , Bessems , J. , Bois , F. Y. , D'Yvoire , M. B. , Buist , H. , Clewell , H. J. 3rd , Meek , B. , Gundert-Remy , U. , Goerlitz , G. and Schmitt , W. 2008 . Development of good modelling practice for physiological based pharmacokinetic models for use in risk assessment: The first steps . Regul Toxicol Pharmacol. , 50 : 400 – 411 .
   PubMed Web of Science ®Google Scholar
• Luebeck , E. G. , Moolgavkar , S. H. , Buchmann , A. and Schwartz , M. 1991 . Effects of polychlorinated biphenyls in rat liver: quantitative analysis of enzyme-altered foci . Toxicol. Appl. Pharmacol. , 111 : 469 – 484 .
   PubMed Web of Science ®Google Scholar
• Luecke , R. H. , Wosilait , W. D. and Young , J. F. 1997 . Mathematical analysis for teratogenic sensitivity . Teratology , 55 : 373 – 380 .
   PubMedGoogle Scholar
• MacDonald , A. J. , Rostami-Hodjegan , A. , Tucker , G. T. and Linkens , D. A. 2002 . Analysis of solvent central nervous system toxicity and ethanol interactions using a human population physiologically based kinetic and dynamic model . Regul. Toxicol. Pharmacol. , 35 : 165 – 176 .
   PubMed Web of Science ®Google Scholar
• Martonen , T. B. , Zhang , Z. , Yu , G. and Musante , C. J. 2001 . Three-dimensional computer modeling of the human upper respiratory tract . Cell Biochem. Biophys. , 35 : 255 – 261 .
   PubMed Web of Science ®Google Scholar
• Meek , M. E. , Beauchamp , R. , Long , G. , Moir , D. , Turner , L. and Walker , M. 2002 . Chloroform: Exposure estimation, hazard characterization, and exposure-response analysis . J. Toxicol. Environ. Health B , 5 : 283 – 334 .
   PubMed Web of Science ®Google Scholar
• Melnick , R. L. and Kohn , M. C. 2000 . Dose-response analyses of experimental cancer data . Drug Metab. Rev. , 32 : 193 – 209 .
   PubMed Web of Science ®Google Scholar
• Miller , F. J. , Schlosser , P. M. and Janszen , D. B. 2000 . Haber's rule: A special case in a family of curves relating concentration and duration of exposure to a fixed level of response for a given endpoint . Toxicology , 149 : 21 – 34 .
   PubMed Web of Science ®Google Scholar
• Monro , A. 1994 . Drug toxicokinetics: Scope and limitations that arise from species differences in pharmacodynamic and carcinogenic responses . J. Pharmacokinet. Biopharm. , 22 : 41 – 57 .
   PubMedGoogle Scholar
• Moolgavkar , S. and Knudson , A. 1981 . Mutation and cancer: A model for human carcinogenesis . J Natl. Cancer Inst. , 66 : 1037 – 1052 .
   PubMed Web of Science ®Google Scholar
• Moolgavkar , S. H. and Luebeck , G. 1990 . Two-event model for carcinogenesis: biological, mathematical, and statistical considerations . Risk Anal. , 10 : 323 – 341 .
   PubMed Web of Science ®Google Scholar
• Moolgavkar , S. and Venzon , D. 1979 . Two-event models for carcinogenesis: Incidence curve for childhood and adult tumors . Math. Biosci. , 47 : 55 – 77 .
   Web of Science ®Google Scholar
• Nong , A. , McCarver , D. G. , Hines , R.N. and Krishnan , K. 2006 . Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene . Toxicol. Appl. Pharmacol. , 214 : 78 – 87 .
   PubMed Web of Science ®Google Scholar
• O'Flaherty , E. J. 1981 . Toxicants and drugs: Kinetics and dynamics , New York : John Wiley & Sons .
   Google Scholar
• O'Flaherty , E. J. 1994 . Physiologic changes during growth and development . Environ. Health Perspect. , 102 ( Suppl. 11 ) : 103 – 106 .
   PubMed Web of Science ®Google Scholar
• Overton , J. H. 2001 . Dosimetry modeling of highly soluble reactive gases in the respiratory tract . Inhal. Toxicol. , 13 : 347 – 357 .
   PubMed Web of Science ®Google Scholar
• Page , N. P. , Singh , D. V. , Farland , W. , Goodman , J. I. , Conolly , R. B. , Andersen , M. E. , Clewell , H. J. , Frederick , C. B. , Yamasaki , H. and Lucier , G. 1997 . Implementation of EPA revised cancer assessment guidelines: Incorporation of mechanistic and pharmacokinetic data . Fundam. Appl. Toxicol. , 37 : 16 – 36 .
   PubMedGoogle Scholar
• Pauluhn , J. 2003 . Issues of dosimetry in inhalation toxicity . Toxicol. Lett. , 140–141 : 229 – 238 .
   PubMed Web of Science ®Google Scholar
• Paustenbach , D. J. 2000 . The practice of exposure assessment: A state-of-the-art review . J. Toxicol. Environ. Health B , 3 : 179 – 291 .
   PubMed Web of Science ®Google Scholar
• Perbellini , L. , Mozzo , P. , Olivato , D. and Brugnone , F. 1990 . "Dynamic" biological exposure indexes for n-hexane and 2,5-hexanedione, suggested by a physiologically based pharmacokinetic model . Am. Ind. Hyg. Assoc. J. , 51 : 356 – 362 .
   PubMed Web of Science ®Google Scholar
• Pierce , C. H. , Dills , R. L. , Morgan , M. S. , Vicini , P. and Kalman , D. A. 1998 . Biological monitoring of controlled toluene exposure . Int. Arch. Occup. Environ. Health , 71 : 433 – 444 .
   PubMed Web of Science ®Google Scholar
• Poet , T. S. , Soelberg , J. J. , Weitz , K. K. , Mast , T. J. , Miller , R. A. , Thrall , B. D. and Corley , R. A. 2003 . Mode of action and pharmacokinetic studies of 2-butoxyethanol in the mouse with an emphasis on forestomach dosimetry . Toxicol. Sci. , 71 : 176 – 189 .
   PubMed Web of Science ®Google Scholar
• Poulin , P. and Krishnan , K. 1996a . A mechanistic algorithm for predicting blood:air partition coefficients of organic chemicals with the consideration of reversible binding in hemoglobin . Toxicol. Appl. Pharmacol. , 136 : 131 – 137 .
   PubMed Web of Science ®Google Scholar
• Poulin , P. and Krishnan , K. 1996b . A tissue composition-based algorithm for predicting tissue:air partition coefficients of organic chemicals . Toxicol. Appl. Pharmacol. , 136 : 126 – 130 .
   PubMed Web of Science ®Google Scholar
• Portier , C. , Tritscher , A. , Kohn , M. , Sewall , C. , Clark , G. , Edler , L. , Hoel , D. and Lucier , G. 1993 . Ligand/receptor binding for 2,3,7,8-TCDD: Implications for risk assessment . Fundam. Appl. Toxicol. , 20 : 48 – 56 .
   PubMedGoogle Scholar
• Portier , C. J. and Kaplan , N. L. 1989 . Variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: Methylene chloride . Fundam. Appl. Toxicol. , 13 : 533 – 544 .
   PubMedGoogle Scholar
• Price , K. , Haddad , S. and Krishnan , K. 2003 . Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children . J. Toxicol. Environ. Health A , 66 : 417 – 433 .
   PubMed Web of Science ®Google Scholar
• Rao , H. V. and Ginsberg , G. L. 1997 . A physiologically-based pharmacokinetic model assessment of methyl t-butyl ether in groundwater for a bathing and showering determination . Risk Anal. , 17 : 583 – 598 .
   PubMed Web of Science ®Google Scholar
• Reddy , C. B. , Yang , R. S. H. , Clewell , H. J. and Andersen , M. E. , eds. 2005 . Physiologically based pharmacokinetic modeling , Hoboken, NJ : Wiley & Sons .
   Google Scholar
• Reitz , R. H. , McDougal , J. N. , Himmelstein , M. W. , Nolan , R. J. and Schumann , A. M. 1988a . Physiologically-based pharmacokinetic modeling with methyl chloroform: Implications for interspecies, high-low dose and dose-route extrapolations . Toxicol. Appl. Pharmacol. , 95 : 185 – 199 .
   PubMed Web of Science ®Google Scholar
• Reitz , R. H. , Mendrala , A. L. , Park , C. N. , Andersen , M. E. and Guengerich , F. P. 1988b . Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: Implications for risk assessment . Toxicol. Lett. , 43 : 97 – 116 .
   PubMed Web of Science ®Google Scholar
• Reitz , R. H. , Mendrala , A. L. and Guengerich , F. P. 1989 . In vitro metabolism of methylene chloride in human and animal tissues: Use in physiologically based pharmacokinetic models . Toxicol. Appl. Pharmacol. , 97 : 230 – 246 .
   PubMed Web of Science ®Google Scholar
• Reitz , R. H. , Mendrala , A. L. , Corley , R. A. , Quast , J. F. , Gargas , M. L. , Andersen , M. E. , Staats , D. A. and Conolly , R. B. 1990a . Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically-based pharmacokinetic modeling . Toxicol. Appl. Pharmacol. , 105 : 443 – 459 .
   PubMed Web of Science ®Google Scholar
• Reitz , R. H. , McCroskey , P. S. , Park , C. N. , Andersen , M. E. and Gargas , M. L. 1990b . Development of a physiologically-based pharmacokinetic model for risk assessment with 1,4-dioxane . Toxicol. Appl. Pharmacol. , 105 : 37 – 54 .
   PubMed Web of Science ®Google Scholar
• Reitz , R. H. , Gargas , M. L. , Andersen , M. E. , Provan , W. M. and Green , T. L. 1996 . Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic model . Toxicol. Appl. Pharmacol. , 137 : 253 – 267 .
   PubMed Web of Science ®Google Scholar
• Renwick , A. G. 2001 . “ Toxicokinetics—Pharmacokinetics in toxicology ” . In Principles and methods of toxicology , Edited by: Hayes , A. W. 137 – 192 . Philadelphia : Taylor & Francis .
   Google Scholar
• Rogers , J. M. , Mole , M. L. , Chernoff , N. , Barbee , B. D. , Turner , C. I. , Logsdon , T. R. and Kavlock , R. J. 1993 . The developmental toxicity of inhaled methanol in the CD-1 mouse, with quantitative dose-response modeling for estimation of benchmark doses . Teratology , 47 : 175 – 188 .
   PubMedGoogle Scholar
• Roth , W. L. , Freeman , R. A. and Wilson , A. G. 1993 . A physiologically based model for gastrointestinal absorption and excretion of chemicals carried by lipids . Risk Anal. , 13 : 531 – 543 .
   PubMed Web of Science ®Google Scholar
• Rowland , M. 1985 . Physiologic pharmacokinetic models and interanimal species scaling . Pharmacol. Ther. , 29 : 49 – 68 .
   PubMed Web of Science ®Google Scholar
• Roy , A. and Georgopoulos , P. G. 1998 . Reconstructing week-long exposures to volatile organic compounds using physiologically based pharmacokinetic models . J. Expos. Anal. Environ. Epidemiol. , 8 : 407 – 422 .
   PubMedGoogle Scholar
• Roy , A. , Weisel , C. P. , Lioy , P. J. and Georgopoulos , P. G. 1996 . A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds . Risk Anal. , 16 : 147 – 160 .
   PubMed Web of Science ®Google Scholar
• Santostefano , M. J. , Wang , X. , Richardson , V. M. , Ross , D. G. , DeVito , M. J. and Birnbaum , L. S. 1998 . A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: Dose- and time-dependent effects . Toxicol. Appl. Pharmacol. , 151 : 294 – 310 .
   PubMed Web of Science ®Google Scholar
• Sarangapani , R. , Gentry , P. R. , Covington , T. R. , Teeguarden , J. G. and Clewell , H. J. III . 2003 . Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors . Inhal. Toxicol. , 15 : 987 – 1016 .
   PubMed Web of Science ®Google Scholar
• Schlosser , P. M. , Lilly , P. D. , Conolly , R. B. , Janszen , D. B. and Kimbell , J. S. 2003 . Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA–protein cross-link dosimetry model to estimate human equivalent doses . Risk Anal. , 23 : 473 – 487 .
   PubMed Web of Science ®Google Scholar
• Simmons , J. E. , Evans , M. V. and Boyes , W. K. 2005 . Moving from external exposure concentration to internal dose: Duration extrapolation based on physiologically based pharmacokinetic derived estimates of internal dose . J. Toxicol. Environ. Health A , 68 : 927 – 950 .
   PubMed Web of Science ®Google Scholar
• Slikker , W. Jr , Andersen , M. E. , Bogdanffy , M. S. , Bus , J. S. , Cohen , S. D. , Conolly , R. B. , David , R. M. , Doerrer , N. G. , Dorman , D. C. , Gaylor , D. W. , Hattis , D. , Rogers , J. M. , Setzer , R. W. , Swenberg , J. A. and Wallace , K. 2004 . Dose-dependent transitions in mechanisms of toxicity: Case studies . Toxicol. Appl. Pharmacol. , 201 : 226 – 294 .
   PubMed Web of Science ®Google Scholar
• Starr , T. B. and Festa , J. L. 2003 . A proposed inhalation reference concentration for methanol . Regul. Toxicol. Pharmacol. , 38 : 224 – 231 .
   PubMed Web of Science ®Google Scholar
• Steinbach , K. H. , Raffler , H. , Pabst , G. and Fliedner , T. M. 1980 . A mathematical model of canine granulocytopoiesis . J. Math. Biol. , 10 : 1 – 12 .
   PubMed Web of Science ®Google Scholar
• Sweeney , L. M. , Tyler , T. R. , Kirman , C. R. , Corley , R. A. , Reitz , R. H. , Paustenbach , D. J. , Holson , J. F. , Whorton , M. D. , Thompson , K. M. and Gargas , M. L. 2001 . Proposed occupational exposure limits for select ethylene glycol ethers using PBPK models and Monte Carlo simulations . Toxicol. Sci. , 62 : 124 – 139 .
   PubMed Web of Science ®Google Scholar
• Tan , Y. M. , Butterworth , B. E. , Gargas , M. L. and Conolly , R. B. 2003 . Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation . Toxicol. Sci. , 75 : 192 – 200 .
   PubMed Web of Science ®Google Scholar
• Tan , Y. M. , Liao , K. H. , Conolly , R. B. , Blount , B. C. , Mason , A. M. and Clewell , H. J. 2006 . Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform . J. Toxicol. Environ. Health A , 69 : 1727 – 1756 .
   PubMed Web of Science ®Google Scholar
• Tardif , R. , Charest-Tardif , G. , Brodeur , J. and Krishnan , K. 1997 . Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans . Toxicol. Appl. Pharmacol. , 144 : 120 – 134 .
   PubMed Web of Science ®Google Scholar
• Thomas , R. S. , Lytle , W. E. , Keefe , T. J. , Constan , A. A. and Yang , R. S. 1996 . Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): A computational method . Fundam. Appl. Toxicol. , 31 : 19 – 28 .
   PubMedGoogle Scholar
• Thomas , R. S. , Conolly , R. B. , Gustafson , D. L. , Long , M. E. , Benjamin , S. A. and Yang , R. S. 2000 . A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator . Toxicol. Appl. Pharmacol. , 166 : 128 – 137 .
   PubMed Web of Science ®Google Scholar
• Timchalk , C. , Nolan , R. J. , Mendrala , A. L. , Dittenber , D. A. , Brzak , K. A. and Mattsson , J. L. 2002 . A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans . Toxicol. Sci. , 66 : 34 – 53 .
   PubMed Web of Science ®Google Scholar
• Timchalk , C. , Poet , T. S. , Kousba , A. A. , Campbell , J. A. and Lin , Y. 2004 . Noninvasive biomonitoring approaches to determine dosimetry and risk following acute chemical exposure: Analysis of lead or organophosphate insecticide in saliva . J. Toxicol. Environ. Health A , 67 : 635 – 650 .
   PubMed Web of Science ®Google Scholar
• Timchalk , C. , Poet , T. S. , Lin , Y. , Weitz , K. K. , Zhao , R. and Thrall , K. D. 2001 . Development of an integrated microanalytical system for analysis of lead in saliva and linkage to a physiologically based pharmacokinetic model describing lead saliva secretion . Am. Ind. Hyg. Assoc. J. , 62 : 295 – 302 .
   Web of Science ®Google Scholar
• Tran , C. L. , Jones , A. D. , Cullen , R. T. and Donaldson , K. 1999 . Mathematical modeling of the retention and clearance of low-toxicity particles in the lung . Inhal. Toxicol. , 11 : 1059 – 1076 .
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency. 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. EPA/600/8–90/066F. Washington, DC: Office of Health and Environmental Assessment http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=71993
   Google Scholar
• U.S. Environmental Protection Agency. 1999a. Extrapolation of the benzene inhalation unit risk estimate to the oral route of exposure (draft). NCEA-W-0517. Washington, DC: National Center for Environmental Assessment. cfm?deid=12140 http://cfpub.epa.gov/ncea/cfm/recordisplay
   Google Scholar
• U.S. Environmental Protection Agency. 1999b. Toxicological review of ethylene glycol monobutyl ether. In support of summary information on the IRIS. CAS No. 111–76–2. Washington, DC: National Center for Environmental Assessment http://www.epa.gov/iris/toxreviews/0500-tr.pdf
   Google Scholar
• U.S. Environmental Protection Agency. 2000a. Benchmark dose technical guidance document (external review draft). EPA/630/R-00/001. Washington, DC: Risk Assessment Forum http://www.epa.gov/ncea/pdfs/bmds/BMD-External_10_13_2000.pdf
   Google Scholar
• U.S. Environmental Protection Agency. 2000b. Toxicological review of vinyl chloride. In support of summary information on the IRIS. EPA/635/R-00/004. Washington, DC: National Center for Environmental Assessment http://www.epa.gov/iris/toxreviews/1001-tr.pdf
   Google Scholar
• U.S. Environmental Protection Agency. 2002. A review of the reference dose and reference concentration processes. EPA/630/P-02/002F. Washington, DC: Risk Assessment Forum http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=55365
   Google Scholar
• U.S. Environmental Protection Agency. 2004. Air quality criteria for particulate matter. EPA/600/P-99/002aF. Research Triangle Park, NC: National Center for Environmental Assessment http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=87903
   Google Scholar
• U.S. Environmental Protection Agency. 2005a. Guidelines for carcinogen risk assessment. EPA/630/P-03/001B. Washington, DC: Risk Assessment Forum http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=116283&CFID=1284815&CFTOKEN=77186427&jsessionid=663067650c6a464245b4TR60306630c230
   Google Scholar
• U.S. Environmental Protection Agency. 2005b. Supplemental guidance for assessing susceptibility from early-life exposure to carcinogens. EPA/630/R-03/003F. Washington, DC: Risk Assessment Forum http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=160003
   Google Scholar
• U.S. Environmental Protection Agency. 2005c. Toxicological review of boron and compounds. In support of summary information on the IRIS. CASRN 7440–42–8. Washington, DC: National Center for Environmental Assessment http://www.epa.gov/iris/toxreviews/0410-tr.pdf
   Google Scholar
• U.S. Environmental Protection Agency. 2006a. Approaches for the application of physiologically based pharmacokinetic (PBPK) models and supporting data in risk assessment. EPA/600/R-05/043F. Washington, DC: National Center for Environmental Assessment http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=157668
   Google Scholar
• U.S. Environmental Protection Agency. 2006b. A framework for assessing health risks of environmental exposures to children. EPA/600/R-05/093F. Washington, DC: National Center for Environmental Assessment. cfm?deid=158363 http://cfpub.epa.gov/ncea/cfm/recordisplay
   Google Scholar
• U.S. Environmental Protection Agency. 2006c. Use of physiologically based pharmacokinetic models to quantify the impact of human age and interindividual differences in physiology and biochemistry pertinent to risk. EPA/600/R-06/014A. Washington, DC: National Center for Environmental Assessment http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=157668
   Google Scholar
• Van Asperen , J. , Rijcken , W. R. P. and Lammers , J. H. C. M. 2003 . Application of physiologically based toxicokinetic modelling to study the impact of the exposure scenario on the toxicokinetics and the behavioural effects of toluene in rats . Toxicol. Lett. , 138 : 51 – 68 .
   PubMed Web of Science ®Google Scholar
• Vinegar , A. and Jepson , G. W. 1996 . Cardiac sensitization thresholds of halon replacement chemicals predicted in humans by physiologically based pharmacokinetic modeling . Risk Anal. , 16 : 571 – 579 .
   PubMed Web of Science ®Google Scholar
• Voisin , E. M. , Ruthsatz , M. , Collins , J. M. and Hoyle , P. C. 1990 . Extrapolation of animal toxicity to humans: Interspecies comparisons in drug development . Regul. Toxicol. Pharmacol. , 12 : 107 – 116 .
   PubMed Web of Science ®Google Scholar
• Wagner , J. G. 1981 . History of pharmacokinetics . Pharmacol. Ther. , 12 : 537 – 562 .
   PubMed Web of Science ®Google Scholar
• Welsch , F. , Blumenthal , G. M. and Conolly , R. B. 1995 . Physiologically based pharmacokinetic models applicable to organogenesis: Extrapolation between species and potential use in prenatal toxicity risk assessments . Toxicol. Lett. , 82–83 : 539 – 547 .
   PubMed Web of Science ®Google Scholar